Therapy-related myeloid neoplasms with isolated del(20q): Comparison with cases of de novo myelodysplastic syndrome with del(20q)

Cancer Genetics

Volumn 206, Issue 1-2, 2013, Pages 42-46

  Kanagal Shamanna, Rashmi ^a   Yin, C Cameron ^a   Miranda, Roberto N ^a   Bueso Ramos, Carlos E ^a   Wang, Xiaohong Iris ^a   Muddasani, Ramya ^a   Medeiros, L Jeffrey ^a   Lu, Gary ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

De novo MDS; Deletion 20q; Myelodysplastic syndrome; Therapy related myeloid neoplasms

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMIFOSTINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; GEMTUZUMAB; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEMOGLOBIN; INTERLEUKIN 3; MITOXANTRONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PACLITAXEL; PREDNISOLONE; RITUXIMAB; THIOTEPA; VINCRISTINE SULFATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 20Q; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MALE; MEAN CORPUSCULAR VOLUME; MULLERIAN PAPILLARY SEROUS CARCINOMA; MYELODYSPLASTIC SYNDROME; NEOPLASM; NEUTROPHIL COUNT; OVERALL SURVIVAL; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; STOMACH CANCER; THERAPY RELATED MYELOID NEOPLASM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TRISOMY 8;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; COHORT STUDIES; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES;

EID: 84873427814     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.12.005     Document Type: Article

References (21)

1. Gupta R., Soupir C.P., Johari V., et al. Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation. Br J Haematol 2007, 139:265-268.
2. Sole F., Luno E., Sanzo C., et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005, 90:1168-1178.
3. Steensma D.P., Dewald G.W., Hodnefield J.M., et al. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?. Leuk Res 2003, 27:235-242.
4. Braun T., de Botton S., Taksin A.L., et al. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases. Leuk Res 2011, 35:863-867.
5. Godley L.A., Larson R.A. Therapy-related myeloid leukemia. Semin Oncol 2008, 35:418-429.
6. Smith S.M., Le Beau M.M., Huo D., et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003, 102:43-52.
7. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer Press, Lyon, France. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
8. Sinsabaugh C. Atypical cytogenetics in therapy-related myelodysplastic syndrome secondary to indolent B-cell lymphoma. Clin Lab Sci 2011, 24:142-146.
9. Fenaux P., Laï J.L., Quiquandon I., et al. therapy related myelodysplastic syndrome and leukemia with no " unfavourable" cytogenetic findings have a good response to intensive chemotherapy: a report on 15 cases. Leuk Lymphoma 1991, 5:117-125.
10. Hao S., Sanger W., Onciu M., et al. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 2002, 15:1266-1272.
11. ISCN 2009: an international system for human cytogenetic nomenclature 2009, Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.).
12. Sun J., Yin C.C., Cui W., et al. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission. Am J Clin Pathol 2011, 135:391-397.
13. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
14. Schoch C., Kern W., Schnittger S., et al. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2003, 18:120-125.
15. Haase D., Germing U., Schanz J., et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007, 110:4385-4395.
16. Schanz J., Tuchler H., Sole F., et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 2012, 30:820-829.
17. Mullier F., Daliphard S., Garand R., et al. Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study. Ann Hematol 2012, 91:203-213.
18. Huh J., Tiu R.V., Gondek L.P., et al. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 2010, 49:390-399.
19. Kurtin P.J., Dewald G.W., Shields D.J., et al. Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients. Am J Clin Pathol 1996, 106:680-688.
20. Greenman C., Stephens P., Smith R., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
21. Bishop R. Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance. Bioscience Horizons 2010, 3:85-95.